Daniel O'Brien, MD
Otolaryngology · Omaha, NENPI 1356699524
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Smith+Nephew at 26.7% of the total. Reporting peaked in 2023 at $5,492 and has fallen 56.0% since, to $2,414 in 2025. Among otolaryngology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $66.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Inspire Medical Systems, Inc.$3K
- Aerin Medical Inc.$2K
- Stryker$831
- Integra Lifesciences Corporation$427
- Sanofi$406
- plus $1K from 13 others
What the payments were for
- Consulting fees$1,31613%
- Travel & lodging$3,06131%
- Food & beverage$5,55056%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 7 | $2,652 |
| Inspire Medical Systems, Inc. | 48 | $2,534 |
| Aerin Medical Inc. | 15 | $1,617 |
| Stryker | 9 | $831 |
| Integra Lifesciences Corporation | 7 | $427 |
| Sanofi | 19 | $406 |
| Medtronic | 5 | $372 |
| AstraZeneca | 8 | $293 |
| Regeneron Healthcare Solutions, Inc. | 10 | $275 |
| Optinose US, Inc. | 4 | $104 |
| Johnson & Johnson | 5 | $84 |
| GSK | 1 | $79 |
| Amgen | 3 | $77 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Genentech USA, Inc. | 2 | $39 |
| Aurinia Pharma U.S., Inc. | 2 | $31 |
| Acclarent, Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Coblation$1,947
- TULA$1,947
- Inspire$1,557
- VIVAER STYLUS$1,206
- TRIGEN$684
- RHINAER STYLUS$406
- N/A$314
- PROPEL$265
- Acclarent Aera$234
- Inspira Air$234
- TruDi Probe$234
- SCOPIS ENT$153
- CORE$147
- RELIEVA SPINPLUS NAV$128
- ESSX$111
How this compares
$9,928 in reported general payments places this provider in the 95th percentile of 86 otolaryngology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $48,612 |
| Ipratropium Bromide | 62 | $1,629 |
| Fluticasone Propionate | 42 | $691 |
| Azelastine Hcl | 23 | $605 |
| Doxycycline Hyclate | 13 | $161 |
| Gabapentin | 24 | $151 |
| Mupirocin | 12 | $123 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $82 |
| Cephalexin | 18 | $66 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Omaha
- Rahul VarmanOmaha$13K
- Wallace DuffOmaha$8K
- Tyler BlissOmaha$4K
- Adam PleasOmaha$4K
- Kyle StansiferOmaha$3K
- Jessica Moran-HansenOmaha$3K
- Jason TalmadgeOmaha$3K
- Thomas DoblemanOmaha$3K
- Stanley SchackOmaha$3K
- Paul SherrerdOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.